{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:40:30Z","timestamp":1761896430991},"reference-count":78,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","diseaseamonth.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.disamonth.2016.08.001","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T18:45:16Z","timestamp":1477334716000},"page":"411-426","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Portal hypertension: Etiology, evaluation, and management"],"prefix":"10.1016","volume":"62","author":[{"given":"Eula Plana","family":"Tetangco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogelio G.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar V.","family":"Lerma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.disamonth.2016.08.001_bib1","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.gie.2012.02.052","article-title":"History of portal hypertension and endoscopic treatment of esophageal varices","volume":"75","author":"Dzeletovic","year":"2012","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"10.1016\/j.disamonth.2016.08.001_bib2","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1053\/j.gastro.2008.03.007","article-title":"Portal hypertension and its complications","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.disamonth.2016.08.001_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0973-6883(11)60128-X","article-title":"Noncirrhotic portal hypertension","volume":"1","author":"Rajekar","year":"2011","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"10.1016\/j.disamonth.2016.08.001_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2036.2008.03729.x","article-title":"Review article: the modern management of portal hypertension\u2014primary and secondary prophylaxis of variceal bleeding in cirrhotic patients","volume":"28","author":"Garcia-Pagan","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.disamonth.2016.08.001_bib5","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"53","author":"de Franchis","year":"2010","journal-title":"J Hepatol"},{"issue":"1 Suppl","key":"10.1016\/j.disamonth.2016.08.001_bib6","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. I. Portal hypertension","volume":"32","author":"Bosch","year":"2000","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.disamonth.2016.08.001_bib7","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.1840400409","article-title":"Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death","volume":"40","author":"Heuman","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.disamonth.2016.08.001_bib8","doi-asserted-by":"crossref","first-page":"203794","DOI":"10.1155\/2012\/203794","article-title":"Clinical manifestations of portal hypertension","volume":"2012","author":"Al-Busafi","year":"2012","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.disamonth.2016.08.001_bib9","doi-asserted-by":"crossref","first-page":"642108","DOI":"10.1155\/2012\/642108","article-title":"Pathogenesis of hepatic encephalopathy","volume":"2012","author":"Cie\u0107ko-Michalska","year":"2012","journal-title":"Gastroenterol Res Pract"},{"issue":"5","key":"10.1016\/j.disamonth.2016.08.001_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2036.2009.04211.x","article-title":"Review article: the modern management of hepatic encephalopathy","volume":"31","author":"Bajaj","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.disamonth.2016.08.001_bib11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.20062","article-title":"The hepatic venous pressure gradient: anything worth doing should be done right","volume":"39","author":"Groszmann","year":"2004","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.disamonth.2016.08.001_bib12","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.3748\/wjg.v20.i15.4300","article-title":"Invasive and non-invasive diagnosis of cirrhosis and portal hypertension","volume":"20","author":"Kim","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.disamonth.2016.08.001_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1586\/egh.12.83","article-title":"Assessing portal hypertension in liver diseases","volume":"7","author":"Berzigotti","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.disamonth.2016.08.001_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/cld.78","article-title":"Approach to the diagnosis of portal hypertension","volume":"1","author":"Koh","year":"2012","journal-title":"Clin Liver Disease"},{"issue":"3","key":"10.1016\/j.disamonth.2016.08.001_bib15","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.disamonth.2016.08.001_bib16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/00365513.2013.879392","article-title":"The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis","volume":"74","author":"Kayadibi","year":"2014","journal-title":"Scand J Clin Lab Invest"},{"issue":"10","key":"10.1016\/j.disamonth.2016.08.001_bib17","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1373\/clinchem.2006.070961","article-title":"A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C","volume":"52","author":"Ngo","year":"2006","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.disamonth.2016.08.001_bib18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cgh.2007.11.009","article-title":"Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C","volume":"6","author":"Patel","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.disamonth.2016.08.001_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.22576","article-title":"Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease","volume":"49","author":"Naveau","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.disamonth.2016.08.001_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2006.09.020","article-title":"Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C","volume":"46","author":"Halfon","year":"2007","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.disamonth.2016.08.001_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.disamonth.2016.08.001_bib22","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.disamonth.2016.08.001_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/gastro\/got007","article-title":"Update of liver fibrosis and steatosis with transient elastography (Fibroscan)","volume":"1","author":"Wong","year":"2013","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"7","key":"10.1016\/j.disamonth.2016.08.001_bib24","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/gut.2006.111302","article-title":"Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease","volume":"56","author":"Fraquelli","year":"2007","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.disamonth.2016.08.001_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.14366\/usg.14003","article-title":"Principles and clinical application of ultrasound elastography for diffuse liver disease","volume":"33","author":"Jeong","year":"2014","journal-title":"Ultrasonography"},{"issue":"5","key":"10.1016\/j.disamonth.2016.08.001_bib26","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1440-1746.2009.05778.x","article-title":"An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis","volume":"24","author":"Carlson","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.disamonth.2016.08.001_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.disamonth.2016.08.001_bib28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2893.2006.00811.x","article-title":"Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases","volume":"14","author":"Coco","year":"2007","journal-title":"J Viral Hepat"},{"issue":"12","key":"10.1016\/j.disamonth.2016.08.001_bib29","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2036.2008.03701.x","article-title":"Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease","volume":"27","author":"Bureau","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.disamonth.2016.08.001_bib30","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/hep.21665","article-title":"Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis","volume":"45","author":"Vizzutti","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.disamonth.2016.08.001_bib31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2006.04.006","article-title":"Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices","volume":"45","author":"Kazemi","year":"2006","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.disamonth.2016.08.001_bib32","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.22870","article-title":"Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography","volume":"49","author":"Masuzaki","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.disamonth.2016.08.001_bib33","first-page":"283","article-title":"Transient elastography for the detection of hepatocellular carcinoma in viral C liver cirrhosis. Is there something else than increased liver stiffness?","volume":"22","author":"Feier","year":"2013","journal-title":"J Gastrointestin Liver Dis"},{"issue":"2","key":"10.1016\/j.disamonth.2016.08.001_bib34","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.22056","article-title":"Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage","volume":"47","author":"Sagir","year":"2008","journal-title":"Hepatology"},{"issue":"20","key":"10.1016\/j.disamonth.2016.08.001_bib35","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.3748\/wjg.v21.i20.6117","article-title":"Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis","volume":"21","author":"Garbuzenko","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.disamonth.2016.08.001_bib36","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-114-10-869","article-title":"Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study","volume":"114","author":"Garc\u00eda-Pag\u00e1n","year":"1991","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.disamonth.2016.08.001_bib37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/gut.42.2.283","article-title":"Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients","volume":"42","author":"Stanley","year":"1998","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.disamonth.2016.08.001_bib38","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.disamonth.2016.08.001_bib39","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2125.1986.tb05237.x","article-title":"Effect of nadolol on liver haemodynamics and function in patients with cirrhosis","volume":"21","author":"Merkel","year":"1986","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.disamonth.2016.08.001_bib40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1475-097X.1987.tb00180.x","article-title":"Long-term effects of beta-adrenergic blockade with nadolol on hepatic and renal haemodynamics and function in cirrhotics","volume":"7","author":"Gatta","year":"1987","journal-title":"Clin Physiol"},{"issue":"6","key":"10.1016\/j.disamonth.2016.08.001_bib41","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/hep.23689","article-title":"Carvedilol for portal hypertension in patients with cirrhosis","volume":"51","author":"Bosch","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.disamonth.2016.08.001_bib42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/00365521.2012.666673","article-title":"Carvedilol or propranolol in portal hypertension? A randomized comparison","volume":"47","author":"Hobolth","year":"2012","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"10.1016\/j.disamonth.2016.08.001_bib43","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","article-title":"Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol","volume":"62","author":"Reiberger","year":"2013","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.disamonth.2016.08.001_bib44","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4253\/wjge.v7.i5.532","article-title":"Is it time to replace propranolol with carvedilol for portal hypertension?","volume":"7","author":"Abid","year":"2015","journal-title":"World J Gastrointest Endosc"},{"issue":"6","key":"10.1016\/j.disamonth.2016.08.001_bib45","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1053\/jhep.2003.50211","article-title":"Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT","volume":"37","author":"Garc\u00eda-Pag\u00e1n","year":"2003","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.disamonth.2016.08.001_bib46","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1111\/j.1572-0241.2007.01564.x","article-title":"Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials","volume":"102","author":"Gluud","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.disamonth.2016.08.001_bib47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1155\/2011\/346705","article-title":"Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysis","volume":"25","author":"Li","year":"2011","journal-title":"Can J Gastroenterol"},{"issue":"4","key":"10.1016\/j.disamonth.2016.08.001_bib48","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1572-0241.2005.40468.x","article-title":"Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding","volume":"100","author":"Sarin","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.disamonth.2016.08.001_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding","volume":"368","author":"Villanueva","year":"2013","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.disamonth.2016.08.001_bib50","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMra0901512","article-title":"Management of varices and variceal hemorrhage in cirrhosis","volume":"362","author":"Garcia-Tsao","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.disamonth.2016.08.001_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM200101043440104","article-title":"Early administration of vapreotide for variceal bleeding in patients with cirrhosis","volume":"344","author":"Cal\u00e8s","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.disamonth.2016.08.001_bib52","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ajg.2008.147","article-title":"Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial","volume":"104","author":"Abid","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.disamonth.2016.08.001_bib53","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0168-8278(97)80248-6","article-title":"Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence","volume":"26","author":"Sarin","year":"1997","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.disamonth.2016.08.001_bib54","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.510290608","article-title":"Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis","volume":"29","author":"Bernard","year":"1999","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.disamonth.2016.08.001_bib55","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/bjs.1800810922","article-title":"Emergency transjugular intrahepatic portosystemic stent shunting as a salvage treatment for uncontrolled variceal hemorrhage","volume":"81","author":"McCormick","year":"1994","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.disamonth.2016.08.001_bib56","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.23383","article-title":"The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009","volume":"51","author":"Boyer","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.disamonth.2016.08.001_bib57","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"issue":"2 Pt 1","key":"10.1016\/j.disamonth.2016.08.001_bib58","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1051-0443(07)61932-0","article-title":"Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts: results of a multivariate analysis","volume":"13","author":"Rajan","year":"2002","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.disamonth.2016.08.001_bib59","doi-asserted-by":"crossref","first-page":"398172","DOI":"10.1155\/2013\/398172","article-title":"Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with recurrent variceal hemorrhage","volume":"2013","author":"Peter","year":"2013","journal-title":"Gastroenterol Res Pract"},{"issue":"4","key":"10.1016\/j.disamonth.2016.08.001_bib60","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/hep.1840380431","article-title":"Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents","volume":"38","author":"Angermayr","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.disamonth.2016.08.001_bib61","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1478-3231.2007.01522.x","article-title":"Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study","volume":"27","author":"Bureau","year":"2007","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.disamonth.2016.08.001_bib62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/0003-4819-117-3-215","article-title":"The serum\u2013ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites","volume":"117","author":"Runyon","year":"1992","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.disamonth.2016.08.001_bib63","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Management of adult patients with ascites due to cirrhosis: update 2012","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.disamonth.2016.08.001_bib64","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1086\/514940","article-title":"Spontaneous bacterial peritonitis","volume":"27","author":"Such","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.disamonth.2016.08.001_bib65","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.disamonth.2016.08.001_bib66","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/bmj.38048.506134.EE","article-title":"Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials","volume":"328","author":"Als-Nielsen","year":"2004","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.disamonth.2016.08.001_bib67","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11011-013-9383-5","article-title":"Antibiotics for the treatment of hepatic encephalopathy","volume":"28","author":"Patidar","year":"2013","journal-title":"Metab Brain Dis"},{"issue":"3","key":"10.1016\/j.disamonth.2016.08.001_bib68","first-page":"617","article-title":"Current trends in the treatment of hepatic encephalopathy","volume":"5","author":"Al Sibae","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.disamonth.2016.08.001_bib69","doi-asserted-by":"crossref","first-page":"489823","DOI":"10.1155\/2010\/489823","article-title":"Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure","volume":"2010","author":"B\u00e9meur","year":"2010","journal-title":"J Nutr Metab"},{"issue":"1","key":"10.1016\/j.disamonth.2016.08.001_bib70","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.26370","article-title":"The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus","volume":"58","author":"Amodio","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.disamonth.2016.08.001_bib71","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11011-012-9372-0","article-title":"Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?","volume":"28","author":"Gluud","year":"2013","journal-title":"Metab Brain Dis"},{"issue":"8","key":"10.1016\/j.disamonth.2016.08.001_bib72","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3945\/jn.113.174375","article-title":"Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials","volume":"143","author":"Gluud","year":"2013","journal-title":"J Nutr"},{"issue":"9","key":"10.1016\/j.disamonth.2016.08.001_bib73","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1365-2036.2010.04448.x","article-title":"Clinical trial: oral zinc in hepatic encephalopathy","volume":"32","author":"Takuma","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.disamonth.2016.08.001_bib74","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1475-2891-12-74","article-title":"A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy","volume":"12","author":"Chavez-Tapia","year":"2013","journal-title":"Nutr J"},{"issue":"4","key":"10.1016\/j.disamonth.2016.08.001_bib75","first-page":"219","article-title":"Sodium benzoate for treatment of hepatic encephalopathy","volume":"9","author":"Misel","year":"2013","journal-title":"Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.disamonth.2016.08.001_bib76","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.21785","article-title":"Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats","volume":"46","author":"Fernandez","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.disamonth.2016.08.001_bib77","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2009.06.024","article-title":"Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats","volume":"51","author":"Reiberger","year":"2009","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.disamonth.2016.08.001_bib78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2036.2011.04896.x","article-title":"The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma\u2014a pilot study","volume":"35","author":"Pinter","year":"2012","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502916300591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502916300591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T20:10:33Z","timestamp":1568491833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502916300591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":78,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0011502916300591"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2016.08.001","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Portal hypertension: Etiology, evaluation, and management","name":"articletitle","label":"Article Title"},{"value":"Disease-a-Month","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.disamonth.2016.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}